This extraction-less kit is a rapid, non-isothermal nucleic acid amplification qSTAR method intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory swabs collected from individuals suspected of COVID-19 by their healthcare provider (HCP).
This test is also authorized for use with swab specimens collected from any individual, including individuals without symptoms or other reasons to suspect COVID-19.
- Reliable and robust performance when compared to traditional RT-PCR tests
- Increased throughput with 5:1 pooling on 96-well RT-PCR instruments
- Direct amplification in under 20 minutes drives lab's efficiency and productivity
- EUA-FDA validated
- Automation compatible
-
Accurate detection with reduced complexity and fast turn-around times
- Excellent sensitivity with CDC-recommended primers and qPCR instruments
- Stringently developed and tested to optimize reproducibility and consistency
- All enzymes are synthesized in the United States
